JPMorgan Chase & Co’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $9 | Hold |
|
|||||
|
2024
Q4 | $17 | Buy |
|
|||||
|
2024
Q3 | $15 | Hold |
|
|||||
|
2024
Q2 | $25 | Hold |
|
|||||
|
2024
Q1 | $33 | Hold |
|
|||||
|
2023
Q4 | $25 | Hold |
|
|||||
|
2023
Q3 | $32 | Hold |
|
|||||
|
2023
Q2 | $31 | Hold |
|
|||||
|
2023
Q1 | $0 | Hold |
|
|||||
|
2022
Q4 | $0 | Sell |
|
|||||
|
2022
Q3 | $21K | Sell |
|
|||||
|
2022
Q2 | $416K | Sell |
|
|||||
|
2022
Q1 | $1.69M | Buy |
|
|||||
|
2021
Q4 | $2.51M | Buy |
|
|||||
|
2021
Q3 | $193K | Sell |
|
|||||
|
2021
Q2 | $676K | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $3K | Buy |
|